Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics Inc (AXSM) and TherapeuticsMD (TXMD)


There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Axsome Therapeutics Inc (AXSM) and TherapeuticsMD (TXMD) with bullish sentiments.

Axsome Therapeutics Inc (AXSM)

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Axsome Therapeutics Inc, with a price target of $30.00. The company’s shares closed last Monday at $21.63.

According to TipRanks.com, Selvaraju is currently ranked with no stars on a 0-5 star ranking scale, with an average return of -17.8% and a 22.4% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Taro Pharmaceutical Industries Ltd., Biospecifics Technologies Corp, and Turning Point Therapeutics Inc.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Axsome Therapeutics Inc with a $37.75 average price target, which is a 73.3% upside from current levels. In a report released yesterday, Guggenheim also initiated coverage with a Buy rating on the stock with a $48.00 price target.

See today’s analyst top recommended stocks >>

TherapeuticsMD (TXMD)

In a report released today, Douglas Tsao from H.C. Wainwright initiated coverage with a Buy rating on TherapeuticsMD and a price target of $7.00. The company’s shares closed last Monday at $3.69.

According to TipRanks.com, Tsao is a 1-star analyst with an average return of -2.6% and a 45.3% success rate. Tsao covers the Healthcare sector, focusing on stocks such as Crinetics Pharmaceuticals Inc, Outlook Therapeutics Inc, and Protagonist Therapeutics.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for TherapeuticsMD with a $12.40 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on TXMD:

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts